Influence of various fast-acting mealtime insulin preparations in individuals with type 1 diabetes, with slow, moderate, and rapid gastric emptying, on postprandial blood glucose and the formation of reactive oxygen species
This study is for people with Type 1 diabetes. Researchers want to understand how different fast-acting insulins, like Lyumjev and Humalog, affect blood sugar levels and other body responses after eating. They are particularly interested in how these insulins work depending on how quickly food leaves a person's stomach, which can vary from person to person. The main goal is to see if one type of insulin helps keep blood sugar levels lower after meals more effectively than others, especially considering individual differences in digestion. They'll also look at how these insulins might affect certain markers in the body related to stress, and how digestion speed changes with different insulins.
At a glance
What is this study about?
This research study is looking at how different types of quick-acting insulins work in people who have Type 1 diabetes. When you eat, your blood sugar goes up, and people with Type 1 diabetes need insulin to help their bodies use this sugar. The speed at which food leaves your stomach can affect how quickly your blood sugar rises, and therefore, how well your mealtime insulin works.
The study compares a newer, very fast-acting insulin (like Lyumjev) with more established rapid-acting insulins (like Humalog) and a standard regular insulin. The main aim is to find out if one of these insulins is better at keeping blood sugar levels stable after a meal, especially considering how fast or slow a person's stomach empties. Researchers believe that some insulins might be more effective depending on a person's digestion speed.
Beyond blood sugar, the study will also look at how insulins affect other things in the body. This includes measuring certain substances in the blood that are linked to stress and inflammation, like 'oxidized LDL' which is sometimes called 'bad' cholesterol. They will also track how quickly food moves through the stomach with each insulin and see if there's a link between digestion speed and blood sugar control. The overall goal is to gain a better understanding of how these different insulins work in real-world situations, helping doctors make more informed choices for people with Type 1 diabetes.
Key takeaways
- Compares different fast-acting insulins for Type 1 diabetes.
- Focuses on how insulins work with varying digestion speeds.
- Aims to find the most effective insulin for post-meal blood sugar control.
- Investigates other body responses, like stress markers.
- Involves detailed monitoring during clinic visits.
Who may be eligible?
This study is open to adults aged 18 and over, and both men and women can take part. To be eligible, you must have Type 1 diabetes.
There might be other specific health requirements or conditions that would prevent you from joining the study. For example, you might not be able to participate if you have certain other medical conditions or are taking specific medications that could interfere with the study results or your safety.
If you're interested, the research team will ask you some questions and might do some checks to make sure the study is a good fit for you and that it's safe for you to take part. This process ensures that the study includes people who will benefit most from the research and whose health conditions allow for accurate and safe participation.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Am I aged 18 or older?
- Do I have Type 1 diabetes?
- Am I generally in good health, apart from my diabetes?
- Am I willing to attend multiple clinic visits?
- Am I able to follow specific meal and insulin instructions?
What does participation involve?
If you decide to take part in this study, you would visit the research clinic on several occasions. During these visits, you'll likely have some basic health checks, blood tests, and receive one of the study insulins to take with a meal. Researchers will then closely monitor your blood sugar levels and other body responses for several hours after eating.
You'll be given specific instructions on how to use the study insulin and what to eat during the study visits. You won't be expected to change your usual diabetes care outside of the study visits unless advised by the research team.
The full duration of your participation in the study, including all the visits and follow-ups, would be explained to you in detail by the research team. They will also tell you about any dietary restrictions or activities you might need to avoid leading up to or during specific study days.
Potential risks and benefits
Locations (1)
- —UnverifiedGermany
Common questions
What is Type 1 diabetes?
Type 1 diabetes is a condition where your body stops making insulin, a hormone needed to turn sugar from food into energy.
What does 'fast-acting insulin' mean?
Fast-acting insulin starts working quickly after you inject it, usually before or just after a meal, to help manage the rise in blood sugar from food.
What is an 'ultra-rapid-acting insulin'?
This is an even faster type of insulin designed to start working almost immediately after injection, aiming to match how quickly blood sugar rises after a meal.
Why is 'gastric emptying' important in this study?
Gastric emptying is how fast food leaves your stomach. If food leaves quickly, your blood sugar might rise faster, so the speed of your insulin needs to match this.
Will I get to keep the new insulin after the study?
The study aims to gather information, not to provide long-term treatment. Any new insulins would only be used during the study visits, and your regular doctor would manage your ongoing care.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.